NLRP3 and chronic obstructive pulmonary disease: These studies may help to identify predictive biomarkers, such as high NLRP3 expression or oxidative stress-related markers, to develop effective combination therapies for pulmonary fibrosis or identify bronchodilators/inhaled glucocorticoids that are effective for chronic obstructive pulmonary disease/asthma patients.